Cyclic Guanosine Monophosphate-Dependent Protein Kinase I Stimulators and Activators Are Therapeutic Alternatives for Sickle Cell Disease.
作者信息
Ghanta Mohankrishna, Panchanathan Elango, Lakkakula Bhaskar Vks
机构信息
Sri Ramachandra Medical College and Research Institute-DU, Faculty of Medicine, Department of Pharmacology, Chennai, Tamil Nadu, India.
Sickle Cell Institute Chhattisgarh, Department of Molecular Genetics, Division of Research, Raipur, Chhattisgarh, India.
出版信息
Turk J Haematol. 2018 Mar 1;35(1):77-78. doi: 10.4274/tjh.2017.0407. Epub 2017 Dec 1.
Abstract
摘要
相似文献
1
Cyclic Guanosine Monophosphate-Dependent Protein Kinase I Stimulators and Activators Are Therapeutic Alternatives for Sickle Cell Disease.
Turk J Haematol. 2018 Mar 1;35(1):77-78. doi: 10.4274/tjh.2017.0407. Epub 2017 Dec 1.
2
Nitric oxide and cyclic GMP levels in sickle cell patients receiving hydroxyurea.
Br J Haematol. 2002 Dec;119(3):855-7. doi: 10.1046/j.1365-2141.2002.03919.x.
3
A New Step in the Treatment of Sickle Cell Disease.
Biochemistry. 2018 Feb 6;57(5):470-471. doi: 10.1021/acs.biochem.7b00785. Epub 2017 Nov 27.
4
Advances in sickle cell disease treatment: from drug discovery until the patient monitoring.
Cardiovasc Hematol Agents Med Chem. 2011 Apr 1;9(2):113-27. doi: 10.2174/187152511796196506.
5
Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors.
Expert Rev Hematol. 2012 Jun;5(3):303-11. doi: 10.1586/ehm.12.20.
6
Sickle-cell anemia: molecular and cellular bases of therapeutic approaches (third of three parts).
N Engl J Med. 1978 Oct 19;299(16):863-70. doi: 10.1056/NEJM197810192991605.
7
Sickle cell disease: role of reactive oxygen and nitrogen metabolites.
Clin Exp Pharmacol Physiol. 2007 Sep;34(9):926-32. doi: 10.1111/j.1440-1681.2007.04639.x.
8
Hydroxyurea and new agents for the treatment of sickle cell disease.
Clin Adv Hematol Oncol. 2004 Nov;2(11):713-5.
9
Hydroxyurea for the treatment of sickle cell anemia.
N Engl J Med. 2008 Mar 27;358(13):1362-9. doi: 10.1056/NEJMct0708272.
10
Developing a pill to treat sickle cell disease.
Science. 2024 Jul 5;385(6704):27-28. doi: 10.1126/science.adq3757. Epub 2024 Jul 4.
引用本文的文献
1
NOS3 gene intron 4 a/b polymorphism is associated with ESRD in autosomal dominant polycystic kidney disease patients.
J Bras Nefrol. 2022 Apr-Jun;44(2):224-231. doi: 10.1590/2175-8239-JBN-2021-0089.
2
Molecular docking analysis of phytoconstituent from Momordica charantia with Guanylate Cyclase catalytic domain.
Bioinformation. 2018 Jul 31;14(7):378-383. doi: 10.6026/97320630014378. eCollection 2018.
本文引用的文献
1
Retrospection on the Role of Soluble Guanylate Cyclase in Parkinson's Disease.
J Pharmacol Pharmacother. 2017 Jul-Sep;8(3):87-91. doi: 10.4103/jpp.JPP_45_17.
2
NOS3 27-bp and IL4 70-bp VNTR Polymorphisms Do Not Contribute to the Risk of Sickle Cell Crisis.
Turk J Haematol. 2016 Dec 1;33(4):365-366. doi: 10.4274/tjh.2016.0166. Epub 2016 Jun 27.
3
Synthetic Peptides as cGMP-Independent Activators of cGMP-Dependent Protein Kinase Iα.
Chem Biol. 2015 Dec 17;22(12):1653-61. doi: 10.1016/j.chembiol.2015.11.005.
4
Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders.
Front Biosci. 2007 Jan 1;12:1107-23. doi: 10.2741/2130.
5
IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formation.
Blood. 2007 Jan 15;109(2):552-9. doi: 10.1182/blood-2005-10-026294. Epub 2006 Sep 21.
6
Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease.
JAMA. 2003 Mar 5;289(9):1136-42. doi: 10.1001/jama.289.9.1136.
7
Mechanism for fetal globin gene expression: role of the soluble guanylate cyclase-cGMP-dependent protein kinase pathway.
Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1847-52. doi: 10.1073/pnas.98.4.1847. Epub 2001 Feb 6.
8
Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase Ibeta.
Nature. 2000 Mar 9;404(6774):197-201. doi: 10.1038/35004606.
9
Requirement for cGMP in nerve cell death caused by glutathione depletion.
J Cell Biol. 1997 Dec 1;139(5):1317-24. doi: 10.1083/jcb.139.5.1317.
Zotero 插件